Some of the most compelling evidence for this came when Novo Nordisk began testing a once-weekly version developed by Knudsens team, called semaglutide
The TV host recently admitted to using Mounjaro after experiencing difficulty in finding the medication
Zooming out, the obesity market is now clearly split across modalities: Novo Nordisk still anchors the peptide side with semaglutide, while oral small molecules are accelerating (orforglipron, elecoglipron and Roches Carmot deal)
Potential cumulative effects, rare adverse events, and interactions that only manifest with extended use remain unknown
Start with small amountsadding fiber too quickly while on a GLP-1 can cause bloating and gas
A physician may review calories, protein intake, fluid intake, blood pressure, blood sugar, sleep quality, thyroid status, anemia risk, kidney function, liver markers, and other medications